Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yui Yamazaki

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Neuroscience Letters|August 9, 2015
Relationship between cerebral sodium-glucose transporter and hyperglycemia in cerebral ischemiaYui Yamazaki, Shinichi Harada, Shogo Tokuyama
European Journal of Pharmacology|January 14, 2018
Sodium-glucose transporter as a novel therapeutic target in diseaseYui Yamazaki, Shinichi Harada, Shogo Tokuyama
Brain Research|October 20, 2012
Post-ischemic hyperglycemia exacerbates the development of cerebral ischemic neuronal damage through the cerebral sodium-glucose transporterYui Yamazaki, Shinichi Harada, Shogo Tokuyama
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|July 3, 2018
[Potential of the Cerebral Sodium-Glucose Transporter as a Novel Therapeutic Target in Cerebral Ischemia]Yui Yamazaki, Shinichi Harada, Shogo Tokuyama
The Journal of Pharmacology and Experimental Therapeutics|November 3, 2012
Orexin-A suppresses postischemic glucose intolerance and neuronal damage through hypothalamic brain-derived neurotrophic factorShinichi Harada, Yui Yamazaki, Shogo Tokuyama
Brain Research|October 19, 2013
Neuroprotective effect through the cerebral sodium-glucose transporter on the development of ischemic damage in global ischemiaShinichi Harada, Yui Yamazaki, Hiroki Nishioka, et al.
Journal of Pharmacological Sciences|December 4, 2018
Activation of c-Jun N-terminal kinase and p38 after cerebral ischemia upregulates cerebral sodium-glucose transporter type 1Yui Yamazaki, Kyoko Arita, Shinichi Harada, et al.
Plos One|April 25, 2014
Hepatic branch vagus nerve plays a critical role in the recovery of post-ischemic glucose intolerance and mediates a neuroprotective effect by hypothalamic orexin-AShinichi Harada, Yui Yamazaki, Shuichi Koda, et al.
ACS Applied Materials & Interfaces|February 17, 2025
Graphene Biosensor Differentiating Sensitive Interactions between Ribonucleic Acid and Dipeptide Repeats in Liquid-Liquid Phase SeparationKantaro Kikuchi, Yui Yamazaki, Kohsuke Kanekura, et al.
Brain Research|February 23, 2017
RETRACTED: Cerebral ischemia-induced elevation of hepatic inflammatory factors accompanied by glucose intolerance suppresses hypothalamic orexin-A-mediated vagus nerve activationShinichi Harada, Yudai Nozaki, Wataru Matsuura, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Neuroscience Letters|August 9, 2015
Relationship between cerebral sodium-glucose transporter and hyperglycemia in cerebral ischemiaYui Yamazaki, Shinichi Harada, Shogo Tokuyama
European Journal of Pharmacology|January 14, 2018
Sodium-glucose transporter as a novel therapeutic target in diseaseYui Yamazaki, Shinichi Harada, Shogo Tokuyama
Brain Research|October 20, 2012
Post-ischemic hyperglycemia exacerbates the development of cerebral ischemic neuronal damage through the cerebral sodium-glucose transporterYui Yamazaki, Shinichi Harada, Shogo Tokuyama
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|July 3, 2018
[Potential of the Cerebral Sodium-Glucose Transporter as a Novel Therapeutic Target in Cerebral Ischemia]Yui Yamazaki, Shinichi Harada, Shogo Tokuyama
The Journal of Pharmacology and Experimental Therapeutics|November 3, 2012
Orexin-A suppresses postischemic glucose intolerance and neuronal damage through hypothalamic brain-derived neurotrophic factorShinichi Harada, Yui Yamazaki, Shogo Tokuyama
Brain Research|October 19, 2013
Neuroprotective effect through the cerebral sodium-glucose transporter on the development of ischemic damage in global ischemiaShinichi Harada, Yui Yamazaki, Hiroki Nishioka, et al.
Journal of Pharmacological Sciences|December 4, 2018
Activation of c-Jun N-terminal kinase and p38 after cerebral ischemia upregulates cerebral sodium-glucose transporter type 1Yui Yamazaki, Kyoko Arita, Shinichi Harada, et al.
Plos One|April 25, 2014
Hepatic branch vagus nerve plays a critical role in the recovery of post-ischemic glucose intolerance and mediates a neuroprotective effect by hypothalamic orexin-AShinichi Harada, Yui Yamazaki, Shuichi Koda, et al.
ACS Applied Materials & Interfaces|February 17, 2025
Graphene Biosensor Differentiating Sensitive Interactions between Ribonucleic Acid and Dipeptide Repeats in Liquid-Liquid Phase SeparationKantaro Kikuchi, Yui Yamazaki, Kohsuke Kanekura, et al.
Brain Research|February 23, 2017
RETRACTED: Cerebral ischemia-induced elevation of hepatic inflammatory factors accompanied by glucose intolerance suppresses hypothalamic orexin-A-mediated vagus nerve activationShinichi Harada, Yudai Nozaki, Wataru Matsuura, et al.
Pageof 2